메뉴 건너뛰기




Volumn 67, Issue 4, 2009, Pages 473-474

Too much effectiveness from a herbal drug

Author keywords

[No Author keywords available]

Indexed keywords

HARPAGOPHYTUM PROCUMBENS EXTRACT; HERBACEOUS AGENT; NIMESULIDE; PC.28 PLUS; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG; VITEX AGNUS CASTUS EXTRACT;

EID: 63849138815     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03365.x     Document Type: Letter
Times cited : (8)

References (6)
  • 2
    • 33645071298 scopus 로고    scopus 로고
    • Feverfew for migraine prophylaxis
    • Henneicke-von Zepelin HH. Feverfew for migraine prophylaxis. Headache 2006 46 : 531.
    • (2006) Headache , vol.46 , pp. 531
    • Henneicke-Von Zepelin, H.H.1
  • 5
    • 0035336686 scopus 로고    scopus 로고
    • Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo
    • Loew D, Mollerfeld J, Schrodter A, Puttkammer S, Kaszkin M. Investigations on the pharmacokinetic properties of Harpagophytum extracts and their effects on eicosanoid biosynthesis in vitro and ex vivo. Clin Pharmacol Ther 2001 69 : 356 64.
    • (2001) Clin Pharmacol Ther , vol.69 , pp. 356-64
    • Loew, D.1    Mollerfeld, J.2    Schrodter, A.3    Puttkammer, S.4    Kaszkin, M.5
  • 6
    • 27444444838 scopus 로고    scopus 로고
    • Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - A randomized, double-blind, multicentre, placebo-controlled study
    • Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke-von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2-extract (MIG-99) in migraine prevention - a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 2005 25 : 1031 41.
    • (2005) Cephalalgia , vol.25 , pp. 1031-41
    • Diener, H.C.1    Pfaffenrath, V.2    Schnitker, J.3    Friede, M.4    Henneicke-Von Zepelin, H.H.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.